연구동향 분석
박사

선천성 면역 및 항 B형간염 타깃 유전자로서 DDX3 RNA helicase 의 기능연구 : Functional Study of DDX3 RNA Helicase on Innate Immunity and Anti-Hepatitis B Activity

강이중 2015년

논문상세정보
인용/피인용
' 선천성 면역 및 항 B형간염 타깃 유전자로서 DDX3 RNA helicase 의 기능연구 : Functional Study of DDX3 RNA Helicase on Innate Immunity and Anti-Hepatitis B Activity' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • ddx3
  • hbv
  • hepatitis b
  • rg3
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
178 0

0.0%

' 선천성 면역 및 항 B형간염 타깃 유전자로서 DDX3 RNA helicase 의 기능연구 : Functional Study of DDX3 RNA Helicase on Innate Immunity and Anti-Hepatitis B Activity' 의 참고문헌

  • Zhu H, Wang Y, Chen J, Cheng G, Xue J. (2004). Transgenic mice expressing hepatitis B virus X protein are more susceptible to carcinogen induced hepatocarcinogenesis. Exp. Mol. Pathol. 76:44-50.
  • Zheng Y, Li J, Johnson DL, Ou JH. (2003). Regulation of hepatitis B virus replication by the rasmitogen- activated protein kinase signaling pathway. J Virol. 77(14):7707?7712.
  • Zanta, M. A., P. Belguise-Valladier, and J. P. Behr. (1999). Gene delivery: a single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus. Proc. Natl. Acad. Sci. 96:91?96.
  • Yun YS, Moon HS, Oh YR, Jo SK, Kim YJ, Yun TK. (1987). Effect of red ginseng on natural killer cell activity in mice with lung adenoma induced by rethan and benzo(a)pyrene. Cancer. Detect. Prev. Suppl. 1:301-309.
  • Yu S, Chen J, Wu M, Chen H, Kato N, Yuan Z. (2010). Hepatitis B virus polymerase inhibits RIGI- and toll-like receptor 3-mediated beta interferon induction in human hepatocytes through interference with interferon regulatory factor 3 activationand dampening of the interaction between TBK1/IKKε abd DDX3. Journal of General Virology. 91:2080?90.
  • Yoo JH, Kwon HC, Kim YJ, Park JH, Yang HO. (2010). KG-135, enriched with selected ginsenosides, inhibits the proliferation of human prostate cancer cells in culture and inhibits xenograft growth in athymic mice. Cancer. Lett. 289:99-110.
  • Yedavalli VS, Neuveut C, Chi YH, Kleiman L, Jeang KT. (2004). Requirement of DDX3 DEAD box RNA helicase for HIV-1 Rev- RRe export function. Cell. 119:381-392
  • Yang X, Gabuzda D. (1999). Regulation of human immunodeficiency virus type 1 infectivity by the ERK mitogen-activated protein kinase signaling pathway. J Virol. 73(4): 3460-3466
  • Yaginuma, K., Y. Shirakata, M. Kobayashi, and K. Koike. (1987). Hepatitis B virus (HBV) particles are produced in a cell culture system by transient expression of transfected HBV DNA. Proc. Natl. Acad. Sci. 84:2678-2682.
  • YH. Hsieh, I.J. Su, H.C. Wang, W.W. Chang, H.Y. Lei, M.D. Lai, W.T.Chang, W. Huang. (2004). Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage. Carcinogenesis. 25:2023-2032.
  • Xu N, Yao HP, Sun Z, Chen Z. (2008). Toll-like receptor 7 and 9 expression in peripheralblood mononuclear cells from patients with chronic hepatitis B and relatedhepatocellular carcinoma. Acta Pharmacologica Sinica. 29:239?44.
  • Wu M., Xu Y, Lin S, Zhang X, Xiang L, Yuan Z. (2007). Hepatitis B virus polymerase inhibits the interferon-inducible MyD88 promoter by blocking nuclear translocation of Stat1. J. Gen. Virol. 88: 3260-3269.
  • Wu J, Meng Z, Jiang M. (2009). Hepatitis B virus suppresses toll-like receptor-mediatedinnate immune responses in murine parenchymal and nonparenchymal livercells. Hepatology . 49:1132?40.
  • Wu J, Lu M, Meng Z, Trippler M, Broering R, Szczeponek A. (2007). Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice. Hepatology . 46:1769- 78.
  • Williams R. (2006). Global challenges in liver disease. Hepatology. 44(3):521?526.
  • Wei Z, Hui TL. (2002). MAPK signal pathways in the regulation of cell proliferation in mammalian cells. Cell Research. 12:9-18
  • Wei XQ, Guo YW, Liu JJ, Wen ZF, Yang SJ, Yao JL. (2008). The significance of Toll-like receptor 4 (TLR4) expression in patients with chronic hepatitis B. Clin. Invest. Med. 31(3):123-130.
  • Wang, G. H., and C. Seeger. (1993). Novel mechanism for reverse transcription in hepatitis B viruses. J. Virol. 67:6507-6512.
  • Wang WH GG, Hullinger RL, Andrisani OM. (2004). Sustained activation of p38 mitogenactivated protein kinase and c-Jun N-terminal kinase pathways by hepatitis B virus X protein mediates apoptosis via induction of Fas/FasL and tumor necrosis factor (TNF) receptor 1/TNF-alpha expression. Mol Cell Biol. 24(23):10352-10365.
  • Wang H, Ryu WS. (2010). Hepatitis B virus polymerase blocks pattern recognition receptor signaling via interaction with DDX3: implications for immune evasion. PLoS Pathog. 6:e1000986.
  • Wang H, Kim S, Ryu WS. (2009). DDX3 DEAD-box RNA helicase inhibits hepatitis B virus reverse transcription by incorporation into nucleocapsids. J. Virol. 83:5815-5824
  • Vogel SN, Fenton M. (2003). Toll-like receptor 4 signalling: new perspectives on a complex signaltransduction problem. Biochem. Soc. Trans. 31:664-668.
  • Van der Molen, RG, Sprengers D, Binda RS, de Jong EC, Niesters HG, Kusters JG, Kwekkeboom J, Janssen HL. (2004). Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B. Hepatology. 40:738- 746.
  • Twu JS, Schloemer RH. (1987). Transcriptional trans-activating function of hepatitis B virus. J Virol 61(11):3448-53.
  • Tsou AP, Kosaka A, Bach C, Zuppan P, Yee C, Tom L, Alvarez R, Ramsey S, Bonhaus DW, Stefanich E. (1994). Cloning and expression of a 5-hydroxytryptamine7 receptor positively coupled to adenylyl cyclase. J Neurochem. 63(2):456-64.
  • Tanner NK, Linder P. (2001). DExD/H box RNA helicases: from generic motors to specific dissociation functions. Mol Cell. 8(2):251-62.
  • Takino Y. (1994). Studies on the pharmacodynamics of ginsenoside-Rg1, -Rb1 and -Rb2 in rats. Yakugaku Zasshi 114(8):550-64.
  • Takeuchi O, Akira S. (2009). Innate immunity to virus infection. Immunol. Rev. 227:75-86.
  • Tagawa, M., W. S. Robinson, and P. L. Marion. (1987). Duck hepatitis B virus replicates in the yolk sac of developing embryos. J. Virol. 61:2273?2279.
  • Tagawa, M., M. Omata, and K. Okuda. (1986). Appearance of viral RNA transcripts in the early stage of duck hepatitis B virus infection. Virology. 152:477?482.
  • Szabo G, Dolganiuc A, Mandrekar P. (2006). Pattern recognition receptors: A contemporary view on liver diseases. Hepatology 44:287-298.
  • Su F, Schneider RJ. (1997). Hepatitis B virus HBx protein sensitizes cells to apoptotic killing by tumor necrosis factor alpha. Proc Natl Acad Sci. 94(16):8744-9.
  • Stoll-Becke, S., R. Repp, D. Glebe, S. Schaefer, J. Kreuder, M. Kann, F.Lampert, and W. H. Gerlich. (1997). Transcription of hepatitis B virus in peripheral blood mononuclear cells from persistently infected patients. J. Virol. 71:5399-5407.
  • Stockl L, Berting A, Malkowski B, Foerste R, Hofschneider PH, Hildt E. (2003). Integrity of c- Raf-1/MEK signal transduction cascade is essential for hepatitis B virus gene expression. Oncogene 22(17):2604-2610.
  • Stam NJ, Roesink C, Dijcks F, Garritsen A, van Herpen A, Olijve W. (1997). Human serotonin 5- HT7 receptor: cloning and pharmacological characterisation of two receptor variants. FEBS Lett. 25;413(3):489-94.
  • Spandau DF, Lee CH. (1988). Trans-activation of viral enhancers by the hepatitis B virus X protein. J Virol. 62(2):427-34.
  • Soulat D. B rckst mmer T, Westermayer S, Goncalves A, Bauch A, Stefanovic A, Hantschel O, Bennett KL, Decker T, Superti-Furga G. (2008). The DEAD-box helicase DDX3X is a critical component of the TANK-binding kinase 1-dependent innate immune response. EMBO J. 27:2135-2146.
  • Soll C, Riener MO, Oberkofler CE, Hellerbrand C, Wild PJ, DeOliveira ML, Clavien PA. (2012). Expression of serotonin receptors in human hepatocellular cancer. Clin Cancer Res. 18(21):5902-10
  • Soldati F, Tanaka O. (1984). Panax ginseng: relation between age of plant and content of ginsenosides. Planta. Med. 50:351-352.
  • Shuping Tong, Jisu Li, and Jack R. (1999). Wands. Carboxypeptidase D Is an Avian Hepatitis B Virus Receptor. Journal of Virology. 73(10): 8696-8702.
  • Shen Y, Monsma FJ Jr, Metcalf MA, Jose PA, Hamblin MW, Sibley DR. (1993). Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype. J Biol Chem. 25;268(24):18200-4.
  • Schr der M, Sutcliffe L. (2010). Consequences of stress in the secretory pathway: The ER stress response and its role in the metabolic syndrome. Methods Mol Biol. 648:43-62.
  • Schr der M, Baran M, Bowie AG. (2008). Viral targeting of DEAD box protein 3 reveals its role in TBK1/IKKe-mediated IRF activation. EMBO J. 27:2147-2157.
  • Schlag EM, Mclntosh MS. (2006). Ginsenoside content and variation among and within American ginseng. Populations Phytochemistry 67:1510-1519.
  • Schaller, H., and M. Fischer. (1991). Transcriptional control of hepadnavirus gene expression. Curr. Top. Microbiol. Immunol. 168:2139.
  • Scaglione F, Ferrara F, Dugnani S, Falchi M, Santoro G, Fraschini F. (1990). Immunomodulatory effects of two extracts of Panax ginseng C.A.Meyer. Drugs. Exp. Clin. Res. 16:537-542.
  • Scaglione F, Cattaneo G, Alessandria M, Cogo R. (1996). Efficacy and safety of the standardized Ginseng extract G115 for potentiating vaccination against the influenza syndrome and protection against the common cold. Drugs. Exp. Clin. Res. 22:65?72.
  • Sanada S, Kondo N, Shoji J, Tanaka O, Shibata S. (1974). Studies on the saponin of ginseng. I. Structures of ginsenoside-Ro, -Rb1, -Rc, and -Rd. Chem. Pharm. Bull. 22:421-428.
  • Rui E, Moura PR, Kobarg J. (2006). Interaction of the hepatitis B virus protein HBx with the human transcription regulatory protein p120E4F in vitro. Virus. Res. 115:31?-42.
  • Ruat M, Traiffort E, Leurs R, Tardivel-Lacombe J, Diaz J, Arrang JM, Schwartz JC. (1993). Molecular cloning, characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation. Proc Natl Acad Sci U S A. 15;90(18):8547-51.
  • Rossner MT. (1992). Review: hepatitis B virus X-geneproduct: a promiscuous transcriptional activator. J. Med. Virol. 36:101-117.
  • Rosner A, Rinkevich B. (2007). The DDX3 subfamily of the DEAD box helicases: divergent roles as unveiled by studying different organisms and in vitro assays. Curr. Med. Chem. 14, 2517- 2525.
  • Rocak S, Linder P. (2004). DEAD-box proteins: the driving forces behind RNA metabolism. Nat Rev Mol Cell Biol. 5(3):232-41.
  • Ren X, Luo G, Xie Z, Zhou L, Kong X, Xu A. (2006). Inhibition of multiple gene expression and virus replication of HBV by stable RNA interference in HepG2.2.15 cells. Journal of Hepatology 44: 663?670.
  • Qadri I, Conaway JW. (1996). Hepatitis B virus transactivator protein, HBx, associates with the components of TFIIH and stimulates the DNA helicase activity of TFIIH. Proc Natl Acad Sci. 93(20):10578-83.
  • Pungpapong S, Kim W, Poterucha J. (2007). Natural History of Hepatitis B Virus Infection. Mayo. Clinic. Proceedings. 82(8):967.
  • Plassat JL, Amlaiky N, Hen R. (1993). Molecular cloning of a mammalian serotonin receptor that activates adenylate cyclase. Mol Pharmacol. 44(2):229-36.
  • Pichlmair A, Reis e Sousa C. (2007). Innate recognition of viruses. Immunity. 27(3):370-83.
  • Paik YH, Schwabe RF, Bataller R, Russo MP, Jobin C, Brenner DA. (2003). Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells. Hepatology 37:1043-1055.
  • Ozkal PI, Ruhi H, Akdogan M, Elhan AH, Kacar S, Sasmaz N. (2005). The genotoxic effects of hepatitis B virus to host DNA. Mutagenesis 20: 147-150.
  • Ou, J. H., H. Bao, C. Shih, and S. M. Tahara. (1990). Preferred translation of human hepatitis B virus polymerase from core protein but not from precore protein-specific transcript. J. Virol. 64:4578-4581.
  • Oshiumi H, Sakai K, Matsumoto M, Seya T. (2010). DEAD/H box 3 (DDX3) helicase binds the RIG-1 adaptor IPS-1 to up-regulate IFN-β inducing potential. Eur. J. Immunol. 40:940- 948.
  • Oshiumi H, Ikeda M, Matsumoto M, Watanabe A, Takeuchi O, Akira S, Kato N, Shimotohno K, Seya T. (2010). Hepatitis C virus core protein abrogates the DDX3 function that enhances IPS-1-mediated IFN-beta induction. PLoS One. 5:e14258.
  • Obosi LA, Hen R, Beadle DJ, Bermudez I, King LA. (1997). Mutational analysis of the mouse 5- HT7 receptor: importance of the third intracellular loop for receptor-G-protein interaction. FEBS Lett. 1997 28;412(2):321-4.
  • Obert, S., B. Zachmann-Brand, E. Deindl, W. Tucker, R. Bartenschlager,and H. Schaller. (1996). A splice hepadnavirus RNA that is essential for virus replication. EMBO J. 15:2565?2574.
  • Nicholas M. Barnes1 and John F. Neumaier. (2011). Neuronal 5-HT Receptors and SERT. Tocris Bioscience Scientific Review Series.34
  • Nicholas M. Barnes, Trevor Sharp. (1999). A review of central 5-HT receptors and their function. Neuropharmacology. 38:1083-1152
  • Newbold, J. E., H. Xin, M. Tencza, G. Sherman, J. Dean, S. Bowden, and S.Locarnini. (1995). The covalently closed duplex form of the hepadnavirus genome exists in situ as a heterogeneous population of viral minichromosomes. J. Virol. 69:3350?3357.
  • Nebigil CG, Choi DS, Dierich A, Hickel P, Le Meur M, Messaddeq N, Launay JM, Maroteaux L. (2000). Serotonin 2B receptor is required for heart development. Proc Natl Acad Sci. 15;97(17):9508-13
  • Nassal M. (1996). Hepatitis B virus morphogenesis. Current Topics in Microbiology and Immunology. 214:297?337.
  • Namba T, Matsushige K, Morita T, Tanaka O. (1986). Saponins of plants of Panax species collected in central Nepal and their chemotaxonomical significance. Chem. Pharm. Bull .34:730-738.
  • Nakamoto Y, Guidotti LG, Kuhlen CV, Fowler P, Chisari FV. (1998). Immune pathogenesis of hepatocellular carcinoma. J. Exp. Med. 188:341-350.
  • Nag SA, Qin JJ, Wang W, Wang MH,Wang H, Zhang R. (2012). Ginsenosides as anticancer agents: in vitro and in vivo activities, structure-activity relationships, and molecular mechanisms of action. Front. Pharmacol. 3,25.
  • Moraleda, G., J. Saputelli, C. E. Aldrich, D. Averett, L. Condreay, and W. S. Mason. (1997). Lack of effect of antiviral therapy in nondividing hepatocyte cultures on the closed circular DNA of woodchuck hepatitis virus. J. Virol. 71:9392?9399.
  • Mohammad-Zadeh LF, Moses L, Gwaltney-Brant SM. (2008). Serotonin: a review. J Vet Pharmacol Ther. 31(3):187-99.
  • McGettrick AF, O Neill LA. (2010). Localisation and trafficking of Toll-like receptors: an important mode of regulation. Curr. Opin. Immunol. 22:20-27.
  • McCaffrey AP, Nakai H, Pandey K, Huang Z, Salazar FH, Xu H, Wieland SF, Marion PL, Kay MA. (2003). Inhibition of hepatitis B virus in mice by RNA interference. Nature Biotechnology 21: 639-644.
  • Matsuura, H., Kasai, R., Tanaka, O., Saruwatari, Y., Kunihiro, K., Fuwa,T.,1984. Further studies on the dammarane-saponins of ginseng roots, Chem. Pharm. Bull. 32, 1188-1192.
  • Mason, W. S., M. S. Halpern, J. M. England, G. Seal, J. Egan, L. Coates,C. Aldrich, and J. Summers. (1983). Experimental transmission of duck hepatitis B virus. Virology. 131:375-384.
  • Madden CR, Finegold MJ, Slagle BL. (2001). Hepatitis B virus X protein acts as a tumor promoter in development of diethylnitrosamine-induced preneoplastic lesions. J. Virol. 75:3851- 3858.
  • Lovenberg TW, Baron BM, de Lecea L, Miller JD, Prosser RA, Rea MA, Foye PE, Racke M, Slone AL, Siegel BW. (1993). A novel adenylyl cyclase-activating serotonin receptor (5- HT7) implicated in the regulation of mammalian circadian rhythms. Neuron. 11(3):449-58.
  • Lorsch JR. (2002). RNA chaperones exist and DEAD box proteins get a life. Cell. 28;109(7):797- 800.
  • Lok AS, Lai CL. (1988). A longitudinal follow-up of asymptomatic hepatitis B surface antigenpositive Chinese children. Hepatology 5:1130-1130
  • Locarnini, S. (2004), Molecular virology of hepatitis B virus. Seminars in liver disease. 241:3-10.
  • Lin X, Yuan ZH, Wu L, Ding JP, Wen YM. (2001). A single amino acid in the reverse transcriptase domain of hepatitis B virus affects virus replication efficiency. J. Virol. 75 :11827?11833.
  • Lim W, Mudge KW, Vermeylen F. (2005). Effects of population, age, and cultivation methods on ginsenoside content of wild American ginseng (Panax quinquefolium). J. Agric Food. Chem. 53:8498-8505.
  • Li W, Gu C, Zhang H, Awang DVC, Fitzloff JF, Fong HHS, Van BRB. (2000). Use of highperformance liquid chromatography-tandem mass spectrometry to distinguish Panax ginseng C.A. meyer (Asian ginseng) and Panax quinquefolius L. (North American ginseng). Anal. Chem. 72:5417-5422.
  • Levine AJ (1997) p53, the cellular gatekeeper for growth and division. Cell 88: 323-331
  • Leemans WF, Janssen HL, Man RA. (2007). Future prospectives for the management of chronic hepatitis B. World Journal of Gastroenterology 13:2554-2567.
  • Lee YH, Yun Y. (1998). HBx protein of hepatitis B virus activates Jak1-STAT signaling. J Biol Chem. 273(39):25510-5.
  • Lee KY, Lee YH, Kim SI, Park JH, Lee SK. (1997). Ginsenoside-Rg5 suppresses cyclin Edependent protein kinase activity via up-regulating p21Cip/WAF1 and down-regulating cyclin E in SK-HEP-1 cells. Anticancer. Res. 17:1067-1072.
  • Lee JY, Ye J, Gao Z, Youn HS, Lee WH, Zhao L, Sizemore N, Hwang DH (2003).Reciprocal modulation of toll-like receptor-4 signaling pathways involving MyD88 andphosphatidylinositol 3-kinase /AKT by saturated and polyunsaturated fatty acids. J BiolChem 278: 37041-37051.
  • Lang T, Lo C, Skinner N, Locarnini S, Visvanathan K, Mansell A. (2011). The hepatitis B e antigen (HBeAg) targets and suppresses activation of the toll-like receptor signaling pathway. Journal of Hepatology . 55:762?9.
  • Landstr m M. (2010). The TAK1?TRAF6 signalling pathway. International Journal of Biochemistry & Cell Biology. 42:585?9.
  • L king A, Stahl U, Schmidt U. (1998). The protein family of RNA helicases. Crit Rev Biochem Mol Biol. 33(4):259-96.
  • Kwon SW, Han SB, Park IH, Kim JM, Park MK, Park JH. (2001). Liquid chromatographic determination of less polar ginsenosides in processed ginseng. J. Chromatogr. A. 921:335-339.
  • Korba, B. E., P. J. Cote, M. Shapiro, R. H. Purcell, and J. L. Gerin. (1989). In vitro production of infectious woodchuck hepatitis virus by lipopolysaccharide stimulated peripheral blood lymphocytes. J. Infect. Dis. 160:572-576.
  • Kong X, San Juan H, Behera A et al. (2004). ERK-1/2 activity is required for efficient RSV infection. FEBS Lett. 3:33?38.
  • Kondo Y, Ueno Y, Shimosegawa T. (2011). Toll-like receptors signaling contributes to immunepathogenesis of HBV infection. Gastroenterology Research and Practice. ID810939.
  • Kock, J., L. Theilmann, P. Galle, and H. J. Schlicht. (1996). Hepatitis B virus nucleic acids associated with human peripheral blood mononuclear cells do not originate from replicating virus. Hepatology. 23:405?413.
  • Kobayashi T, Walsh MC, Choi Y. (2004). The role of TRAF6 in signal transduction and immune response. Microbes Infect. 6:1333-1338.
  • Klein NP, Schneider RJ. (1997). Activation of Src family kinases by hepatitis B virus HBx protein and coupled signaling to Ras. Mol Cell Biol. 17(11):6427-36.
  • Kim WY, Kim JM, Han SB, Lee SK, Kim ND, Park MK, Kim CK, Park JH. (2000). Steaming of ginseng at high temperature enhances biological activity. J. Nat. Prod. 63:1702-1704.
  • Kim KH, Seong BL. (2003). Pro-apoptotic function of HBV X protein is mediated by interaction with c-FLIP and enhancement of death-inducing signal. EMBO. J. 22: 2104?2116.
  • Kim JY, Germolec DR, Luster MI. (1990). Panax ginseng as a potential immunomodulator: studies in mice. Immunopharmacol Immunotoxicol 12:257?276.
  • Kim HJ, Yoo HS, Kim JC, Park CS, Choi MS, Kim MJ, Choi HS, Min JS, Kim YS, Yoon SW, Ahn JK. (2009). Antiviral effect of Curcuma longa Linn extract against hepatitis B virus replication. Journal of Ethnopharmacology 124:189-196
  • Kim HE, Ishihara A, Lee SG. (2012). The effects of Caffeoylserotonin on inhibition of melanogenesis through the downregulation of MITF via the reduction of intracellular cAMP and acceleration of ERK activation in B16 murine melanoma cells. BMB Rep.;45(12):724-9.
  • Kim EJ, Lee HI, Chung KJ. (2009). The ginsenoside-Rb2 lowers cholesterol and triacylglycerol levels in 3T3-L1 adipocytes cultured under high cholesterol or fatty acids conditions. BMB. Rep. 42(4):194-199.
  • Kekule AS, Lauer U, Weiss L, Luber B, Hofschneider PH. (1993). Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathway. Nature 361:742-745.
  • Karin M. (1995). The regulation of AP-1 activity by mitogen-activated protein kinases. Journal of Biological Chemistry. 270:16483?6.
  • Kann, M., B. Sodeik, A. Vlachou, W. H. Gerlich, and A. Helenius. (1997). Phosphorylationdependent binding of hepatitis B virus core particles to the nuclear pore complex. J. Cell Biol. 145:45?55.
  • Kann, M., A. Bischof, and W. H. Gerlich. (1997). In vitro model for the nuclear transport of the hepadnavirus genome. J. Virol. 71:1310?1316.
  • Kang LJ, Choi YJ, Lee SG. (2013). Stimulation of TRAF6/TAK1 degradation and inhibition of JNK/AP-1 signalling by ginsenoside Rg3 attenuates hepatitis B virus replication. Int J Biochem Cell Biol. 45(11):2612-21.
  • Kaneko H, Nakanishi K. (2004). Proof of the mysterious efficacy of ginseng: basic effects of medical ginseng, Korean red ginseng: its anti-stress action for prevention of disease. J Pharmacol Sci. 95:158-162.
  • Kalra N, Kumar V. (2006). The X protein of hepatitis B virus binds to the F box protein Skp2 and inhibits the ubiquitination and proteasomal degradation of c-Myc. FEBS. Lett. 580: 431? 436.
  • Jinsheng G, Scott L, Friedman. (2010). Toll-like receptor 4 signaling in liver injury and hepatic fibrogenesis. Fibrogenesis Tissue Repair 3:21-40.
  • Jilbert, A. R., J. S. Freiman, E. J. Gowans, M. Holmes, Y. E. Cossart, and C. J. Burrell. (1987). Duck hepatitis B virus DNA in liver, spleen, and pancreas: analysis by in situ and Southern blot hybridization. Virology. 158:330?338
  • Isogawa M, Robek MD, Furuichi Y, Chisari FV. (2005). Toll-like receptor signalinginhibits hepatitis B virus replication in vivo. Journal of Virology. 79:7269?72.
  • I Merican, R Guan, D Amarapuka. (2000). Chronic hepatitis B virus infection in Asian countries. Journal of Gastroenterology and Hepatology 15:1356?1361
  • I Chemin, H Ohgaki, FV Chisari. (1999). Wild, Altered expression of hepatic carcinogen metabolizing enzymes with liver injury in HBV transgenic mouse lineages expressing various amounts of hepatitis B surface antigen. Liver. 19:81?87.
  • Hussain MJ, Lau JYN, Williams R, Vergani D. (1994). Hepatic expression of tumour necro-sis factor- _ in chronic hepatic B virus infection. Journal of Clinical Pathology.47:1112?5.
  • Hupp TR, Lane DP. (1994). Allosteric activation of latent p53 tetramers. Curr. Biol. 4:865-875.
  • Huang, M., and J. Summers. (1994). Pet, A small sequence distal to the pregenome cap site, is required for expression of the duck hepatitis B virus pregenome. J. Virol. 68:1564?1572.
  • Huang KL, Lai YK, Lin CC, Chang JM. (2006). Inhibition of hepatitis B virus production by Boehmeria nivea root extract in HepG2 2.2.15 cells. World. J. Gastroenterol. 12(35): 5721-5725
  • Hirt B. (1967). Selective extraction of polyma DNA from infected mouse cell cultures. J.Mol. Biol. 26:365-369.
  • Hirst WD, Price GW, Rattray M, Wilkin GP. (1997). Identification of 5-hydroxytryptamine receptors positively coupled to adenylyl cyclase in rat cultured astrocytes. Br J Pharmacol. 120(3):509-15.
  • Hildt E, Munz B, Saher G, Reifenberg K, Hofschneider PH. (2002). The PreS2 activator MHBs(t) of hepatitis B virus activates craf-1/Erk2 signaling in transgenic mice. EMBO J. 21(4):525?535.
  • Henkler F, Waseem N, Golding MH, Alison MR, Koshy R. (1995). Mutant p53 but not hepatitis B virus X protein is present in hepatitis B virus-related human hepatocellular carcinoma. Cancer res. 55:6084
  • Heidmann DE, Metcalf MA, Kohen R, Hamblin MW. (1997). Four 5-hydroxytryptamine7 (5-HT7) receptor isoforms in human and rat produced by alternative splicing: species differences due to altered intron-exon organization. J Neurochem. 4:1372-81.
  • Hacker H, Karin M. (2006). Regulation and function of IKK and IKK-related kinases. Sci. 357:13. Heermann KH, F Kruse, M Seifer, WH Gerlich. (1987). Immunogenicity of the gene S and Pre-S domains in hepatitis B virions and HBsAg filaments. Intervirology 28:14?25.
  • Guo L, Guo Y, Xiao S, Shi X. (2005). Protein kinase p-JNK is correlated with the activationof AP-1 and its associated Jun family proteins in hepatocellular carcinoma. LifeSciences . 77:1869?78.
  • Glebe, D; Urban, S. (2007). Viral and cellular determinants involved in hepadnaviral entry. World journal of gastroenterology. 13(1): 22?38
  • Ginseng-HCC chemopreventive study Osaka group. (2001). Study on chemoprevention ofhepatocellular carcinoma by ginseng: an introduction to the protocol. Journal of Korean Medical Science. 16:S70?4.
  • Garrington TP, & Johnson GL(1999). Organization and regulation of mitogen-activated protein kinase signaling pathways. Curr Opin Cell Biol, 11(2):211-218.
  • Ganem D, Prince AM. (2004). Hepatitis B virus infection?natural history and clinical consequences. New England Journal of Medicine 350: 1118?1129.
  • Ganem D, J R Pollack, J Tavis. (1994). Hepatitis B virus reverse transcriptase and its many roles in hepadnaviral genomic replication. Infect. Agents. Dis. 3:85?93.
  • Fischer M, Runkel L, Schaller H. (1995). HBx protein of hepatitis B virus interacts with the Cterminal portion of a novel human proteasome alpha-subunit. Virus Genes. 10(1):99-102.
  • Feitelson MA, Lee J. (2007). Hepatitis B virus integration, fragile sites, and hepatocarcinogenesis. Cancer. Lett. 252:157-170.
  • Farrell GC, Teoh NC. (2006). Management of chronic hepatitis B virus infection: a new era of disease control. Internal Medicine Journal 36:100?113.
  • Dunn C, Brunetto M, Reynolds G, Christophides T, Kennedy PT, Lampertico P. (2007). Cytokines induced during chronic hepatitis B virus infection promotes a path-way for NK cell-mediated liver damage. Journal of Experimental Medicine. 204:667?80.
  • Dixit VP, Jain P, Joshi SC. (1988). Hypolipidaemic effects of Curcuma longa L and Nardostachys jatamansi DC in triton-inducedhyperlipidaemic rats. Indian Journal of Physiology and Pharmacology 32:299-304.
  • David E. Nichols, and Charles D. Nichols. (2008). Serotonin Receptors. Chem Rev. 108:1614-1641.
  • Cyong JC, Ki SM, Lijima K, Kobayashi T, Furuya M. (2000). Clinical and pharmacological studies on liver diseases treated with Kampo herbal medicine. American Journal of Chinese Medicine . 28:351?60
  • Court WA, Reynolds LB, Hendel JG. (1996). Influence of root age on the concentration of ginsenosides of American ginseng. Can. J. Plant. Sci. 76:853-855
  • Cougot DY, Wu S, Cairo J, Caramel CA, Renard L, L vy MA, et al. (2007). The hepatitisB virus X protein functionally interacts with CREB-binding protein/p300 inthe regulation of CREB-mediated transcription. Journal of Biological Chemistry. 282:4277?87
  • Cooper A, Tal G, Lider O, Shaul Y. (2005). Cytokine induction by the hepatitis B virus capsidin macrophages is facilitated by membrane heparin sulfate and involves TLR2. Journal of Immunology .175:3165?76.
  • Choi YJ, Kang LJ, Lee SG.. (2014). Stimulation of DDX3 expression by ginsenoside Rg3 through the Akt/p53 pathway activates the innate immune response via TBK1/IKKε/IRF3 signalling. Curr Med Chem. 21(8):1050-60.
  • Choi Y, Lee SG. (2012). The DEAD-box RNA helicase DDX3 interacts with DDX5, co-localizes with it in the cytoplasm during the G2/M phase of the cycle, and affects its shuttling during mRNP export. J.Cell. Biochem. 113:985-996.
  • Cheng AS, Wong N, Tse AM, Chan KY, Chan KK, Sung JJ, Chan HL. (2008). RNA interference targeting HBx suppresses tumor growth and enhances cisplatin chemosensitivity in human hepatocellular carcinoma. Cancer. Lett. 253:43-52.
  • Chen CF, Chiou WF, Zhang JT. (2008). Comparison of the pharmacological effects of Panax ginseng and Panax quinquefolium. Acta. Pharmacol. Sin. 29(9):1103-8.
  • Chao CH, Chen CM, Cheng PL, Shih JW, Tsou AP, Lee YH. (2006). DDX3, a DEAD box RNA helicase with tumor growthsuppressive property and transcriptional regulation activity of the p21waf1/clp1 promoter, as a candidate tumor suppressor. Cancer Res. 66:6579-6588.
  • Chang, M. (2007). Hepatitis B virus infection. Seminars in fetal & neonatal medicine. 12(3): 160? 167.
  • Chan DW, Ng IO. (2006). Knock-down of hepatitis B virus X protein reduces the tumorigenicity of hepatocellular carcinoma cells. J. Pathol. 208:372-380.
  • Chae HB, Kim JH, Kim JK, Yim HJ. (2009). Current status of liver diseases in Korea: Hepatitis B. Korean. J. Hepatol. 6:S13-S24.
  • Botlagunta M, Vesuna F, Mironchik Y, Raman A, Lisok A, Winnard P.Jr, Mukadam S, Van Diest P, Chen JH, Farabaugh P, Patel AH, Raman V. (2008). Oncogenic role of DDX3 in breast cancer biogenesis. Oncogene, 2008, 27, 3912-3922.
  • Birnbaum F, Nassal M. (1990). Hepatitis B virus nucleocapsid assembly: primary structurerequirements in the core protein. Journal of Virology. 64:3319?30..
  • Barker and L. F. (1970). Transmission of serum hepatitis. JAMA. 211:1509-1512.
  • Bard JA, Zgombick J, Adham N, Vaysse P, Branchek TA, Weinshank RL. (1993). Cloning of a novel human serotonin receptor (5-HT7) positively linked to adenylate cyclase. J Biol Chem. 5;268(31):23422-6.
  • Attele AS, Wu JA, Yuan CS. (1999). Multiple pharmacological effects of ginseng. Biochem. Pharmacol. 58:1685?93.
  • Assinewe VA, Baum BR, Gagnon D, Arnason JT. (2003). Phytochemistry of wild populations of Panax quinquefolium L. J. Agric. Food. Chem. 51:4549-4553.
  • Arndt PG, Suzuki N, Avdi NJ, Malcolm KC, Worthen GS. (2004). Lipopoly saccharideinduced c- Jun NH2-terminal kinase activation in human neutrophils: role of phosphatidylinositol 3- Kinase and Syk-mediated pathways. J. Biol. Chem. 279:10883-10891.
  • Ariumi Y, Kuroki M, Abe K, Dansako H, Ikeda M, Wakita T, Kato N. (2007). DDX3 DEAD-box RNA helicase is required for hepatitis C RNA replication. J. Virol. 81:13922-13926.
  • Arii M, Takada S, Koike K. (1992). Identification of three essential regions of hepatitis B virus X protein for trans-activation function. Oncogene. 7:397-403.
  • Aldrich, C. E, L. Coates, T. T. Wu, J. Newbold, B. C. Tennant, J. Summers, C. Seeger, and W. S. Mason. (1989). In vitro infection of woodchuck hepatocytes with woodchuck hepatitis virus and ground squirrel hepatitis virus. Virology. 172:247?252.
  • ?Akira S, Uematsu S, Takeuchi O. (2006). Pathogen recognition and innate immunity. Cell. 24;124(4):783-801.